NASDAQ: VOGX
Vogenx Inc Stock Forecast, Predictions & Price Target

Analyst price target for VOGX

Based on 2 analysts offering 12 month price targets for Vogenx Inc

Min Forecast
$42.00+109.37%
Avg Forecast
$48.50+141.77%
Max Forecast
$55.00+174.18%

Should I buy or sell VOGX stock?

Based on 2 analysts offering ratings for Vogenx Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although VOGX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates VOGX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their VOGX stock forecasts and price targets.

VOGX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-02
lockedlocked$00.00+00.00%2026-09-01

1 of 1

Forecast return on equity

Is VOGX forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is VOGX forecast to generate an efficient return on assets?

Company
-4,204.68%
Industry
-5.56%
VOGX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VOGX earnings per share forecast

What is VOGX's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.62
Avg 2 year Forecast
-$1.55
Avg 3 year Forecast
-$3.99

VOGX revenue forecast

What is VOGX's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

VOGX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VOGX$20.06$48.50+141.77%Strong Buy
LXEO$3.62$13.67+277.54%Strong Buy
PRLD$3.79$9.67+155.07%Strong Buy
IPSC$1.61$6.50+303.73%Buy
VNDA$4.81$14.00+191.06%Strong Buy

Vogenx Stock Forecast FAQ

Is Vogenx Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: VOGX) stock is to Strong Buy VOGX stock.

Out of 2 analysts, 1 (50%) are recommending VOGX as a Strong Buy, 1 (50%) are recommending VOGX as a Buy, 0 (0%) are recommending VOGX as a Hold, 0 (0%) are recommending VOGX as a Sell, and 0 (0%) are recommending VOGX as a Strong Sell.

If you're new to stock investing, here's how to buy Vogenx stock.

What is VOGX's earnings growth forecast for 2026-2028?

(NASDAQ: VOGX) Vogenx's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.35%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 64.91%.

Vogenx's earnings in 2026 is N/A.On average, 4 Wall Street analysts forecast VOGX's earnings for 2026 to be -$9,167,074, with the lowest VOGX earnings forecast at -$10,045,010, and the highest VOGX earnings forecast at -$8,110,878. On average, 3 Wall Street analysts forecast VOGX's earnings for 2027 to be -$23,031,327, with the lowest VOGX earnings forecast at -$22,128,138, and the highest VOGX earnings forecast at -$23,708,719.

In 2028, VOGX is forecast to generate -$59,245,058 in earnings, with the lowest earnings forecast at -$56,921,722 and the highest earnings forecast at -$60,987,560.

What is VOGX's revenue growth forecast for 2026-2028?

(NASDAQ: VOGX) Vogenx's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 43.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.2%.

Vogenx's revenue in 2026 is N/A.On average, 4 Wall Street analysts forecast VOGX's revenue for 2026 to be $0, with the lowest VOGX revenue forecast at $0, and the highest VOGX revenue forecast at $0. On average, 3 Wall Street analysts forecast VOGX's revenue for 2027 to be $0, with the lowest VOGX revenue forecast at $0, and the highest VOGX revenue forecast at $0.

In 2028, VOGX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is VOGX's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: VOGX) forecast ROA is -4,204.68%, which is lower than the forecast US Biotechnology industry average of -5.56%.

What is VOGX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year VOGX price target, the average VOGX price target is $48.50, with the highest VOGX stock price forecast at $55.00 and the lowest VOGX stock price forecast at $42.00.

On average, Wall Street analysts predict that Vogenx's share price could reach $48.50 by Sep 2, 2027. The average Vogenx stock price prediction forecasts a potential upside of 141.77% from the current VOGX share price of $20.06.

What is VOGX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: VOGX) Vogenx's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that VOGX's EPS will be -$0.62 for 2026, with the lowest EPS forecast at -$0.68, and the highest EPS forecast at -$0.55. On average, analysts forecast that VOGX's EPS will be -$1.55 for 2027, with the lowest EPS forecast at -$1.49, and the highest EPS forecast at -$1.60. In 2028, VOGX's EPS is forecast to hit -$3.99 (min: -$3.83, max: -$4.11).

What is VOGX's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: VOGX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.